Won-Serk Kim Selected Research

Solid-State Lasers

2/2020	A Split-Face, Single-Blinded, Randomized Controlled Comparison of 532 nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser versus 532 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Solar Lentigines.
12/2017	Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
8/2017	Beneficial Effect of Low Fluence 1,064 nm Q-Switched Neodymium:Yttrium-Aluminum-Garnet Laser in the Treatment of Senile Lentigo.
1/2015	Beneficial effects of early treatment of nevus of Ota with low-fluence 1,064-nm Q-switched Nd:YAG laser.
7/2014	Treatment of nevus of Ota using low fluence Q-switched Nd:YAG laser.
12/2011	Prevention of thyroidectomy scars in Asian adults using a 532-nm potassium titanyl phosphate laser.
6/2010	Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Won-Serk Kim Research Topics

Disease

6	Wounds and Injuries (Trauma) 02/2013 - 07/2009
5	Hypoxia (Hypoxemia) 08/2016 - 07/2009
4	Alopecia (Baldness) 01/2024 - 01/2011
4	Cicatrix (Scar) 01/2019 - 11/2006
3	Nevus (Nevi) 05/2021 - 04/2013
3	Hyperpigmentation 02/2020 - 07/2014
3	Pain (Aches) 01/2018 - 01/2011
3	Melanosis (Freckles) 12/2017 - 06/2010
2	Neoplasms (Cancer) 11/2023 - 09/2020
2	Skin Diseases (Skin Disease) 09/2023 - 02/2016
2	Diabetes Mellitus 05/2023 - 02/2009
2	Hyperhidrosis 01/2022 - 08/2008
2	Edema (Dropsy) 01/2021 - 12/2015
2	Keloid 11/2020 - 01/2013
2	Inflammation (Inflammations) 09/2020 - 01/2011
2	Lentigo (Lentiginosis) 02/2020 - 08/2017
2	Erythema 01/2017 - 12/2015
2	Acne Vulgaris 10/2016 - 01/2011
2	Syringoma 06/2016 - 03/2007
2	Nevus of Ota 01/2015 - 07/2014
1	Alopecia Areata 01/2024
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Seborrheic Dermatitis 09/2023
1	Herpes Simplex 05/2023
1	Primary Cutaneous Amyloidosis 05/2023
1	Amyloidosis 05/2023
1	Drug Eruptions (Drug Eruption) 05/2023
1	Exanthema (Rash) 05/2023
1	Hypertrichosis 05/2021
1	Ecchymosis 01/2021
1	Hemorrhage 01/2021
1	Lipoma (Lipomata) 01/2021
1	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2019
1	Neuralgia (Stump Neuralgia) 01/2018
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2018
1	Syphilis 12/2017
1	Rosacea (Acne Rosacea) 10/2016

Drug/Important Bio-Agent (IBA)

5	NeodymiumIBA 02/2020 - 01/2015
4	yttrium-aluminum-garnetIBA 02/2020 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 07/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2016 - 08/2012
3	CollagenIBA 09/2013 - 07/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 07/2009
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2012 - 07/2009
3	Conditioned Culture MediaIBA 02/2010 - 04/2008
2	Neutralizing AntibodiesIBA 01/2024 - 07/2009
2	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 06/2016
2	SteroidsIBA 11/2020 - 02/2009
2	SolutionsIBA 09/2020 - 12/2019
2	Insulin-Like Growth Factor Binding ProteinsIBA 08/2016 - 02/2010
2	Messenger RNA (mRNA)IBA 08/2016 - 07/2009
2	ErbiumIBA 01/2011 - 08/2009
1	Chemokine ReceptorsIBA 01/2024
1	Amyloid (Amyloid Fibrils)IBA 05/2023
1	Valacyclovir (Valtrex)FDA LinkGeneric 05/2023
1	Insulin (Novolin)FDA Link 05/2023
1	Acyclovir (Aciclovir)FDA LinkGeneric 05/2023
1	incobotulinumtoxinA FDA Link 01/2022
1	Tranexamic Acid (AMCA)FDA Link 01/2021
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 11/2020
1	Epidermal Growth Factor (EGF)IBA 09/2020
1	EpiregulinIBA 09/2020
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 12/2019
1	AluminumIBA 01/2019
1	YttriumIBA 01/2019
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Lactoylglutathione LyaseIBA 01/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	ReaginsIBA 12/2017
1	hydroquinone (Esoterica)FDA Link 12/2017
1	Melanins (Melanin)IBA 01/2017
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 10/2016
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2016
1	Photosensitizing Agents (Photosensitizers)IBA 10/2016
1	alexandriteIBA 10/2016
1	Small Interfering RNA (siRNA)IBA 08/2016

Therapy/Procedure

13	Lasers (Laser) 05/2021 - 03/2007
7	Therapeutics 01/2024 - 07/2014
7	Solid-State Lasers 02/2020 - 06/2010
2	Radiotherapy 11/2023 - 11/2020
2	Cryotherapy (Therapy, Cold) 09/2023 - 11/2020
2	Dye Lasers 10/2016 - 08/2009
2	Gas Lasers 06/2016 - 04/2013
2	Low-Level Light Therapy (LLLT) 12/2015 - 01/2011
2	Thyroidectomy 12/2011 - 08/2009
1	Adjuvant Radiotherapy 11/2023
1	Injections 05/2023
1	Hair Removal (Depilation) 05/2021
1	Intralesional Injections 11/2020
1	Aftercare (After-Treatment) 12/2017
1	Semiconductor Lasers 10/2016
1	Photochemotherapy (Photodynamic Therapy) 10/2016
1	Laser Therapy (Surgery, Laser) 10/2016